Surprisingly, this CNX-mutant PLP1 binding delays the elimination of mutant protein from the cells through the ER-associated degradation (ERAD), suggesting that this glycan-independent binding of ER chaperones possibly contributes to the pathology of PMD. Here, PLP1 is linked to Pelizeaus-Merzbacher spectrum disorder.